(Q40529159)

21 September 2017

title

Comparison of HPV DNA vaccines employing intracellular targeting strategies (English)

1 reference

21 September 2017

J W Kim

1

1 reference

21 September 2017

C-F Hung

2

1 reference

21 September 2017

J Juang

3

1 reference

21 September 2017

L He

4

1 reference

21 September 2017

T Woo Kim

5

1 reference

21 September 2017

D K Armstrong

6

1 reference

21 September 2017

S I Pai

7

1 reference

21 September 2017

P-J Chen

8

1 reference

21 September 2017

C-T Lin

9

1 reference

21 September 2017

D A Boyd

10

1 reference

21 September 2017

T-C Wu

11

1 reference

21 September 2017

publication date

1 June 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

11

1 reference

21 September 2017

issue

12

1 reference

21 September 2017

page(s)

1011-1018

1 reference

Exposing the immunology of naked DNA vaccines

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Molecular characterization of defective antigen processing in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

1 reference

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

7 January 2021

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

7 January 2021

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

7 January 2021

Loss of MHC class-I expression in cervical carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302252

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302252

1 reference

Dimensions Publication ID

21 September 2017

1024719788

0 references

1 reference